Much of our knowledge regarding the interactions between epithelial tissues and the immune system has been gathered from animal models and co-cultures with cell lines. However, unique features of human cells cannot be modelled in mice, and cell lines are often transformed or genetically immortalized. Organoid technology has emerged as a powerful tool to maintain epithelial cells in a near-native state. In this Review, we discuss how organoids are being used in immunological research to understand the role of epithelial cell–immune cell interactions in tissue development and homeostasis, as well as in diseases such as cancer.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice
Nature Biotechnology Open Access 26 January 2023
Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
Cell Death & Disease Open Access 11 January 2023
Uncovering the mode of action of engineered T cells in patient cancer organoids
Nature Biotechnology Open Access 25 July 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Ganusov, V. V. & De Boer, R. J. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 28, 514–518 (2007).
Kobayashi, T., Naik, S. & Nagao, K. Choreographing immunity in the skin epithelial barrier. Immunity 50, 552–565 (2019).
McNamara, H. A. & Cockburn, I. A. The three Rs: recruitment, retention and residence of leukocytes in the liver. Clin. Transl Immunology 5, e123 (2016).
Rankin, L. C. & Artis, D. Beyond host defense: emerging functions of the immune system in regulating complex tissue physiology. Cell 173, 554–567 (2018).
Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667–685 (2014).
Rheinwald, J. G. & Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331–343 (1975).
Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009). This article describes the first robust, adult stem cell-derived organoid system to be developed.
Ootani, A. et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nat. Med. 15, 701–706 (2009).
Hu, H. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175, 1591–1606.e19 (2018).
Huch, M. et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247–250 (2013).
Peng, W. C. et al. Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture. Cell 175, 1607–1619.e15 (2018).
Chacon-Martinez, C. A., Klose, M., Niemann, C., Glauche, I. & Wickstrom, S. A. Hair follicle stem cell cultures reveal self-organizing plasticity of stem cells and their progeny. EMBO J. 36, 151–164 (2017).
Snippert, H. J. et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327, 1385–1389 (2010).
Boonekamp, K. E. et al. Long-term expansion and differentiation of adult murine epidermal stem cells in 3D organoid cultures. Proc. Natl Acad. Sci. USA 116, 14630–14638 (2019).
Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).
Barker, N. et al. Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6, 25–36 (2010).
Huch, M. et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J. 32, 2708–2721 (2013).
Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 38, e100300 (2019). In this study, the authors report a triple co-culture of human airway organoids with respiratory syncytial virus and neutrophils.
Lugli, N. et al. R-spondin 1 and noggin facilitate expansion of resident stem cells from non-damaged gallbladders. EMBO Rep. 17, 769–779 (2016).
Mullenders, J. et al. Mouse and human urothelial cancer organoids: a tool for bladder cancer research. Proc. Natl Acad. Sci. USA 116, 4567–4574 (2019).
Kretzschmar, K. & Clevers, H. Organoids: modeling development and the stem cell niche in a dish. Dev. Cell 38, 590–600 (2016).
Takasato, M. et al. Kidney organoids from human IPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015).
McCracken, K. W. et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516, 400–404 (2014).
Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).
Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47 (2015).
Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407–418 (2018).
Lehle, A. S. et al. Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency. Gastroenterology 156, 275–278 (2019).
Schutgens, F. et al. Tubuloids derived from human adult kidney and urine for personalized disease modeling. Nat. Biotechnol. 37, 303–313 (2019).
Co, J. Y. et al. Controlling epithelial polarity: a human enteroid model for host–pathogen interactions. Cell Rep. 26, 2509–2520.e4 (2019).
Sachs, N., Tsukamoto, Y., Kujala, P., Peters, P. J. & Clevers, H. Intestinal epithelial organoids fuse to form self-organizing tubes in floating collagen gels. Development 144, 1107–1112 (2017).
Moon, C., VanDussen, K. L., Miyoshi, H. & Stappenbeck, T. S. Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis. Mucosal Immunol. 7, 818–828 (2014).
VanDussen, K. L. et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64, 911–920 (2015).
Ettayebi, K. et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 353, 1387–1393 (2016).
Mebius, R. E., Streeter, P. R., Michie, S., Butcher, E. C. & Weissman, I. L. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+ CD3– cells to colonize lymph nodes. Proc. Natl Acad. Sci. USA 93, 11019–11024 (1996).
Hashi, H. et al. Compartmentalization of Peyer’s patch anlagen before lymphocyte entry. J. Immunol. 166, 3702–3709 (2001).
Baptista, A. P. et al. Colonic patch and colonic silt development are independent and differentially regulated events. Mucosal Immunol. 6, 511–521 (2013).
Fordham, R. P. et al. Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell 13, 734–744 (2013).
Schreurs, R. et al. Human fetal TNF-α-cytokine-producing CD4+ effector memory T cells promote intestinal development and mediate inflammation early in life. Immunity 50, 462–476.e8 (2019). In this study, the authors model the interaction between T cells and inflamed intestine using organoids derived from patients with inflammatory bowel disease.
Rothenberg, E. V., Moore, J. E. & Yui, M. A. Launching the T-cell-lineage developmental programme. Nat. Rev. Immunol. 8, 9–21 (2008).
Alexandropoulos, K. & Danzl, N. M. Thymic epithelial cells: antigen presenting cells that regulate T cell repertoire and tolerance development. Immunol. Res. 54, 177–190 (2012).
Pinto, S. et al. An organotypic coculture model supporting proliferation and differentiation of medullary thymic epithelial cells and promiscuous gene expression. J. Immunol. 190, 1085–1093 (2013).
Chung, B. et al. Engineering the human thymic microenvironment to support thymopoiesis in vivo. Stem Cell 32, 2386–2396 (2014).
Fan, Y. et al. Bioengineering thymus organoids to restore thymic function and induce donor-specific immune tolerance to allografts. Mol. Ther. 23, 1262–1277 (2015).
Tajima, A. et al. Bioengineering mini functional thymic units with EAK16-II/EAKIIH6 self-assembling hydrogel. Clin. Immunol. 160, 82–89 (2015).
Parent, A. V. et al. Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell 13, 219–229 (2013).
Sun, X. et al. Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell 13, 230–236 (2013).
Bonfanti, P. et al. Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells. Nature 466, 978–982 (2010).
Wong, K. et al. Multilineage potential and self-renewal define an epithelial progenitor cell population in the adult thymus. Cell Rep. 8, 1198–1209 (2014).
Luan, R., Liang, Z., Zhang, Q., Sun, L. & Zhao, Y. Molecular regulatory networks of thymic epithelial cell differentiation. Differentiation 107, 42–49 (2019).
Dudakov, J. A. et al. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease. Blood 130, 933–942 (2017).
Wertheimer, T. et al. Production of BMP4 by endothelial cells is crucial for endogenous thymic regeneration. Sci. Immunol. 3, eaal2736 (2018).
van den Brink, M. R., Alpdogan, O. & Boyd, R. L. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat. Rev. Immunol. 4, 856–867 (2004).
Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339–350 (2012).
Peterson, L. W. & Artis, D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141–153 (2014).
Price, A. E. et al. A map of Toll-like receptor expression in the intestinal epithelium reveals distinct spatial, cell type-specific, and temporal patterns. Immunity 49, 560–575.e6 (2018). This study shows that organoids derived from different anatomical locations along the gut retain patterns of TLR expression according to their location of origin.
Farin, H. F. et al. Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-gamma. J. Exp. Med. 211, 1393–1405 (2014).
Nagashima, K. et al. Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat. Immunol. 18, 675–682 (2017).
Powell, N., Walker, M. M. & Talley, N. J. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat. Rev. Gastroenterol. Hepatol. 14, 143–159 (2017).
Biton, M. et al. T helper cell cytokines modulate intestinal stem cell renewal and differentiation. Cell 175, 1307–1320.e22 (2018). Using single-cell transcriptomics, the authors here show that intestinal stem cells can function as non-classical antigen-presenting cells and that activated T cell-derived cytokines influence the differentiation of the intestinal epithelium.
de Lau, W. et al. Peyer’s patch M cells derived from Lgr5+ stem cells require SpiB and are induced by RankL in cultured ‘miniguts’. Mol. Cell Biol. 32, 3639–3647 (2012).
Gerbe, F. et al. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature 529, 226–230 (2016).
Lo, D. D. Vigilance or subversion? Constitutive and inducible M cells in mucosal tissues. Trends Immunol. 39, 185–195 (2018).
Reboldi, A. et al. IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches. Science 352, aaf4822 (2016).
Rios, D. et al. Antigen sampling by intestinal m cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria. Mucosal Immunol. 9, 907–916 (2016).
Kanaya, T. et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat. Immunol. 13, 729–736 (2012).
Rouch, J. D. et al. Development of functional microfold (M) cells from intestinal stem cells in primary human enteroids. PLOS ONE 11, e0148216 (2016).
Basak, O. et al. Induced quiescence of Lgr5+ stem cells in intestinal organoids enables differentiation of hormone-producing enteroendocrine cells. Cell Stem Cell 20, 177–190.e4 (2017).
Beumer, J. et al. Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient. Nat. Cell Biol. 20, 909–916 (2018).
Howitt, M. R. et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science 351, 1329–1333 (2016).
von Moltke, J., Ji, M., Liang, H. E. & Locksley, R. M. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529, 221–225 (2016).
Haber, A. L. et al. A single-cell survey of the small intestinal epithelium. Nature 551, 333–339 (2017).
Kanaya, T. et al. Development of intestinal M cells and follicle-associated epithelium is regulated by TRAF6-mediated NF-κB signaling. J. Exp. Med. 215, 501–519 (2018).
Kimura, S. et al. Sox8 is essential for M cell maturation to accelerate IgA response at the early stage after weaning in mice. J. Exp. Med. 216, 831–846 (2019).
Jinnohara, T. et al. IL-22BP dictates characteristics of Peyer’s patch follicle-associated epithelium for antigen uptake. J. Exp. Med. 214, 1607–1618 (2017).
Waddell, A., Vallance, J. E., Hummel, A., Alenghat, T. & Rosen, M. J. IL-33 induces murine intestinal goblet cell differentiation indirectly via innate lymphoid cell IL-13 secretion. J. Immunol. 202, 598–607 (2019).
Gerbe, F., Legraverend, C. & Jay, P. The intestinal epithelium tuft cells: specification and function. Cell Mol. Life Sci. 69, 2907–2917 (2012).
Nadjsombati, M. S. et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity 49, 33–41e7 (2018).
Schneider, C. et al. A metabolite-triggered tuft cell-ILC2 circuit drives small intestinal remodeling. Cell 174, 271–284.e14 (2018).
Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560–564 (2015). The authors describe a co-culture of ILC3s with intestinal organoids, showing that IL-22 is necessary for intestinal regeneration following injury.
Jung, K. B. et al. Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids. Nat. Commun. 9, 3039 (2018).
Delespine-Carmagnat, M., Bouvier, G. & Bertoglio, J. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain. Eur. J. Immunol. 30, 59–68 (2000).
Liu, R. et al. Constitutive STAT5 activation regulates Paneth and Paneth-like cells to control Clostridium difficile colitis. Life Sci. Alliance 2, e201900296 (2019).
Masopust, D., Vezys, V., Wherry, E. J., Barber, D. L. & Ahmed, R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 176, 2079–2083 (2006).
Cheroutre, H., Lambolez, F. & Mucida, D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445–456 (2011).
Lefrancois, L. & Puddington, L. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu. Rev. Immunol. 24, 681–704 (2006).
Ariotti, S. et al. Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc. Natl Acad. Sci. USA 109, 19739–19744 (2012).
Ariotti, S. et al. T cell memory: skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert. Science 346, 101–105 (2014).
Jiang, X. et al. Skin infection generates non-migratory memory CD8+ Trm cells providing global skin immunity. Nature 483, 227–231 (2012).
Wakim, L. M., Woodward-Davis, A. & Bevan, M. J. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl Acad. Sci. USA 107, 17872–17879 (2010).
Hofmann, M. & Pircher, H. E-cadherin promotes accumulation of a unique memory CD8 T-cell population in murine salivary glands. Proc. Natl Acad. Sci. USA 108, 16741–16746 (2011).
Nozaki, K. et al. Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes. J. Gastroenterol. 51, 206–213 (2016).
Rogoz, A., Reis, B. S., Karssemeijer, R. A. & Mucida, D. A 3-D enteroid-based model to study T-cell and epithelial cell interaction. J. Immunol. Methods 421, 89–95 (2015). These authors present a method for co-culturing intestinal organoids with intraepithelial lymphocytes and also show that the organoids promote the differentiation of naive T cells into an intraepithelial lymphocyte-like phenotype.
Gebhardt, T. et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477, 216–219 (2011).
Sujino, T. et al. Tissue adaptation of regulatory and intraepithelial CD4+ T cells controls gut inflammation. Science 352, 1581–1586 (2016).
Hoytema van Konijnenburg, D. P. et al. Intestinal epithelial and intraepithelial T cell crosstalk mediates a dynamic response to infection. Cell 171, 783–794.e13 (2017).
Dutta, D., Heo, I. & Clevers, H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol. Med. 23, 393–410 (2017).
Kotloff, K. L. et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, gems): a prospective, case-control study. Lancet 382, 209–222 (2013).
McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O’Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87–103 (2015).
Persson, B. D., Jaffe, A. B., Fearns, R. & Danahay, H. Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLOS ONE 9, e102368 (2014).
Chen, Y. W. et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell Biol. 19, 542–549 (2017).
Heo, I. et al. Modelling cryptosporidium infection in human small intestinal and lung organoids. Nat. Microbiol. 3, 814–823 (2018).
Barrila, J. et al. Modeling host–pathogen interactions in the context of the microenvironment: three-dimensional cell culture comes of age. Infect. Immun. 86, e00282–18 (2018).
Lukovac, S. et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio 5, e01438–14 (2014).
Tan, J. K., McKenzie, C., Marino, E., Macia, L. & Mackay, C. R. Metabolite-sensing G protein-coupled receptors—facilitators of diet-related immune regulation. Annu. Rev. Immunol. 35, 371–402 (2017).
Goverse, G. et al. Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells. J. Immunol. 198, 2172–2181 (2017).
Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).
Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).
Tang, Y., Chen, Y., Jiang, H., Robbins, G. T. & Nie, D. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int. J. Cancer 128, 847–856 (2011).
Singh, N. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128–139 (2014).
Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor Gpr43. Nature 461, 1282–1286 (2009).
Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159–166 (2014).
Lukasova, M., Malaval, C., Gille, A., Kero, J. & Offermanns, S. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor Gpr109a expressed by immune cells. J. Clin. Invest. 121, 1163–1173 (2011).
Luu, M. et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic–epigenetic crosstalk in lymphocytes. Nat. Commun. 10, 760 (2019).
Marshall, B. J. & Warren, J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311–1315 (1984).
Holokai, L. et al. Increased programmed death-ligand 1 is an early epithelial cell response to Helicobacter pylori infection. PLOS Pathog. 15, e1007468 (2019). In this study, the authors establish a co-culture of CTLs with Helicobacter pylori-infected gastric organoids, which is one of only a few examples of a triple co-culture to be published as of yet.
Mor, S. M. et al. Expectoration of cryptosporidium parasites in sputum of human immunodeficiency virus-positive and -negative adults. Am. J. Trop. Med. Hyg. 98, 1086–1090 (2018).
Chen, P. et al. Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. Science 360, 664–669 (2018).
Saavedra, P. H. V. et al. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis. Nat. Commun. 9, 4846 (2018).
Liu, L. et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151–2161 (2012).
Hunter, P. R. & Nichols, G. Epidemiology and clinical features of cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev. 15, 145–154 (2002).
Checkley, W. et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect. Dis. 15, 85–94 (2015).
Driehuis, E. et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 9, 852–871 (2019).
Karin, M. & Clevers, H. Reparative inflammation takes charge of tissue regeneration. Nature 529, 307–315 (2016).
Aparicio-Domingo, P. et al. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage. J. Exp. Med. 212, 1783–1791 (2015).
Nusse, Y. M. et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559, 109–113 (2018). This study shows that intestinal injury results in the appearance of fetal-like characteristics in the intestinal epithelium during recovery.
Mustata, R. C. et al. Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium. Cell Rep. 5, 421–432 (2013).
Ricklin, D., Reis, E. S. & Lambris, J. D. Complement in disease: a defence system turning offensive. Nat. Rev. Nephrol. 12, 383–401 (2016).
Matsumoto, N. et al. C3a enhances the formation of intestinal organoids through C3aR1. Front. Immunol. 8, 1046 (2017). The authors show using organoids that complement factors have a role in intestinal regeneration following injury.
Mastellos, D., Papadimitriou, J. C., Franchini, S., Tsonis, P. A. & Lambris, J. D. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J. Immunol. 166, 2479–2486 (2001).
Strey, C. W. et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198, 913–923 (2003).
Haynes, T. et al. Complement anaphylatoxin C3a is a potent inducer of embryonic chick retina regeneration. Nat. Commun. 4, 2312 (2013).
Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017).
Sachs, N. & Clevers, H. Organoid cultures for the analysis of cancer phenotypes. Curr. Opin. Genet. Dev. 24, 68–73 (2014).
Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011).
van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015). van de Wetering et al. provide the first description of a biobank of tumour organoids derived from patients with colorectal cancer.
Fujii, M. et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827–838 (2016).
Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424–1435 (2017).
Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346–354 (2013).
Roerink, S. F. et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556, 457–462 (2018).
Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).
Zumwalde, N. A. et al. Analysis of immune cells from human mammary ductal epithelial organoids reveals Vδ2+ T cells that efficiently target breast carcinoma cells in the presence of bisphosphonate. Cancer Prev. Res. 9, 305–316 (2016). This study describes a holistic-approach-based co-culture for the outgrowth of tumour-reactive γδ T cells.
Finnberg, N. K. et al. Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures. Oncotarget 8, 66747–66757 (2017).
Jenkins, R. W. et al. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids. Cancer Discov. 8, 196–215 (2018). The authors show that organotypic tumour cultures provide a platform for assessing the response to PD1 blockade.
Deng, J. et al. CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation. Cancer Discov. 8, 216–233 (2018).
Neal, J. T. et al. Organoid modeling of the tumor immune microenvironment. Cell 175, 1972–1988.e16 (2018).
Chakrabarti, J. et al. Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer. Oncotarget 9, 37439–37457 (2018).
Chakrabarti, J. et al. Mouse-derived gastric organoid and immune cell co-culture for the study of the tumor microenvironment. Methods Mol. Biol. 1817, 157–168 (2018).
Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207–211 (2015).
Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015).
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015).
Keenan, T. E., Burke, K. P. & Van Allen, E. M. Genomic correlates of response to immune checkpoint blockade. Nat. Med. 25, 389–402 (2019).
Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577–581 (2014).
Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409–413 (2017).
Yarchoan, M., Johnson, B. A. 3rd, Lutz, E. R., Laheru, D. A. & Jaffee, E. M. Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer 17, 569 (2017).
Efremova, M., Finotello, F., Rieder, D. & Trajanoski, Z. Neoantigens generated by individual mutations and their role in cancer immunity and immunotherapy. Front. Immunol. 8, 1679 (2017).
Lennerz, V. et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl Acad. Sci. USA 102, 16013–16018 (2005).
Wolchok, J. D. et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N. Engl. J. Med. 377, 1345–1356 (2017).
Wolfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281–1284 (1995).
Drost, J. et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358, 234–238 (2017).
Dijkstra, K. K. et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174, 1586–1598.e12 (2018). This study shows that tumour-derived organoids can be used as a platform to expand tumour-specific T cells.
Kong, J. C. H. et al. Tumor-infiltrating lymphocyte function predicts response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. JCO Precis. Oncol. https://doi.org/10.1200/PO.18.00075 (2018).
June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64–73 (2018).
Bonifant, C. L., Jackson, H. J., Brentjens, R. J. & Curran, K. J. Toxicity and management in CAR T-cell therapy. Mol. Ther. Oncolytics 3, 16011 (2016).
Schnalzger, T. E. et al. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. EMBO J. 38, e100928 (2019). This report describes a method to assess CAR-mediated antigen-specific killing of colorectal cancer organoids.
Gan, H. K., Cvrljevic, A. N. & Johns, T. G. The epidermal growth factor receptor variant III (EGFRviii): where wild things are altered. FEBS J. 280, 5350–5370 (2013).
de Lau, W. et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476, 293–297 (2011).
Koo, B. K. et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665–669 (2012).
Gurney, A. et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc. Natl Acad. Sci. USA 109, 11717–11722 (2012).
Kretzschmar, K. & Clevers, H. Wnt/beta-catenin signaling in adult mammalian epithelial stem cells. Dev. Biol. 428, 273–282 (2017).
Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268–1273 (2012).
Sommer, F. & Backhed, F. The gut microbiota - masters of host development and physiology. Nat. Rev. Microbiol. 11, 227–238 (2013).
Berkers, G. et al. Rectal organoids enable personalized treatment of cystic fibrosis. Cell Rep. 26, 1701–1708.e3 (2019).
Dekkers, J. F. et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19, 939–945 (2013).
Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373–386.e310 (2018).
The authors thank J. Bernink, R. Millen and T. Mizutani for comments and advice on the manuscript. This work was supported by the gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO) and the European Research Council (Advanced Grant ERC-AdG 67013-Organoid, to H.C.), and by a VENI grant from the Netherlands Organisation for Scientific Research (Grant NWO-ZonMW, 016.166.140, to K.K.). This work is part of the Oncode Institute, which is partly funded by the Dutch Cancer Society. K.K. is a long-term fellow of the Human Frontier Science Program Organization (HFSPO, LT771/2015).
The authors are inventors on patent applications and/or patents for organoid culture and organoid–immune cell co-cultures.
Peer review information
Nature Reviews Immunology thanks N. C. Zachos and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Feeder cell
A cell line generated from isolated neonatal murine fibroblasts that have been selected for supporting optimal growth of epidermal keratinocytes in 2D culture.
- Pluripotent stem cells
(PSCs). Cells with the potential to generate all embryonic tissues, such as embryonic stem cells.
- Induced pluripotent stem cells
(iPSCs). Pluripotent cells generated in culture by the (over)expression of defined genetic factors in non-pluripotent cells such as somatic cells.
- Intestinal stem cells
(ISCs). Rapidly dividing, LGR5+ columnar crypt bottom cells from which all cells in the intestinal epithelium arise.
- Necrotizing enterocolitis
A condition that typically occurs in newborns, in which a part of the intestine dies.
- Positive selection
The process leading to the proliferation and survival of thymocytes that have successfully recombined the T cell receptor locus to express a functional T cell receptor on their cell surface.
- Negative selection
The process leading to clonal deletion of thymocytes that express a T cell receptor that binds to self-peptide–MHC complexes presented in the thymic medulla.
- Nude mice
Mice that are athymic (lacking a thymus) and therefore lack mature, functional T cells and are severely immune deficient.
- Tuft cells
A subset of chemosensory cells in the intestinal and airway epithelium.
- Enteroendocrine cells
A group of specialized hormone-producing intestinal epithelial cells.
- Goblet cells
A subset of mucus-producing cells found in the intestinal and airway epithelium.
- Group 2 innate lymphoid cells
(ILC2s). A subset of innate lymphocytes (that is, lymphocytes that do not express an antigen receptor) that produce type 2 cytokines (such as IL-5 and IL-13) upon stimulation.
- Peripherally induced regulatory T cells
Regulatory T cells that differentiate from naive T cells in the periphery, as opposed to naturally occurring regulatory T cells that develop in the thymus.
- Group 3 innate lymphoid cells
(ILC3s). A subset of innate lymphocytes (that is, lymphocytes that do not express an antigen receptor) that produce TH17 cell-associated cytokines (such as IL-17A and IL-22) upon stimulation.
- Air–liquid interphase
A culture method in which cells are grown in a monolayer on a transwell, allowing for contact both with air and with a culture medium in the bottom well.
- Graft-versus-host disease
A condition occurring upon allogeneic bone marrow transplantation in which graft-derived immune cells mount an immune response against the host tissues.
- Patient-derived xenograft
A system in which pieces of patient-derived tumour material (including the entire tumour microenvironment — in other words, immune cells, endothelial cells and fibroblasts, as well as the tumour epithelium) are transplanted into immunocompromised mice, which allows for the study of tumour behaviour in an in vivo system.
- Organotypic tumour spheroids
A culture system in which pieces of tumour (including the entire tumour microenvironment — in other words, immune cells, endothelial cells and fibroblasts, as well as the tumour epithelium) are brought into culture, which allows for the study of tumour characteristics in vitro.
Rights and permissions
About this article
Cite this article
Bar-Ephraim, Y.E., Kretzschmar, K. & Clevers, H. Organoids in immunological research. Nat Rev Immunol 20, 279–293 (2020). https://doi.org/10.1038/s41577-019-0248-y
This article is cited by
Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
Cell Death & Disease (2023)
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice
Nature Biotechnology (2023)
Uncovering the mode of action of engineered T cells in patient cancer organoids
Nature Biotechnology (2023)
A roadmap for translational cancer glycoimmunology at single cell resolution
Journal of Experimental & Clinical Cancer Research (2022)
Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations
Journal of Nanobiotechnology (2022)